Cimigenol depresses acute myeloid leukemia cells protected by breaking bone marrow stromal cells via CXCR4/SDF‑1α

The purpose of the present study was to evaluate cimigenol (Cim) treatment effects to cell proliferation by breaking bone marrow stromal cells (BMSCs) through C-X-C chemokine receptor type 4 (CXCR4)/stromal cell-derived factor-1α (SDF-1α) pathway. MV-4-11 and U937 cell lines were used. The present s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Bangyun, Dai, Huibo, Dai, Xingbin, Qian, Shushu, Sha, Xiaocao, Sun, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842948/
https://www.ncbi.nlm.nih.gov/pubmed/36684661
http://dx.doi.org/10.3892/etm.2022.11779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842948/
https://www.ncbi.nlm.nih.gov/pubmed/36684661
http://dx.doi.org/10.3892/etm.2022.11779

Ejemplares similares